Advanced Solid Tumors: MK-8294 Treatment

We are evaluating a new treatment called MK-8294 for people with advanced solid tumors. The study aims to understand its safety and how well it works.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Clinical Research Unit
Amstelveen, Netherlands
Radboud universitair medisch centrum Stichting
Medical Oncology
Nijmegen, Netherlands
Sponsor: Merck Sharp & Dohme LLC
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.